US Broker Ratings

Novavax, Inc. (NVAX) Stock Analysis: A Look at Its 51.3% Potential Upside

Novavax, Inc. (NASDAQ: NVAX) is a prominent player in the biotechnology sector, focusing on the development and commercialization of vaccines. Best known for its COVID-19 vaccine,..

National HealthCare Corporation (NHC) Stock Analysis: Navigating Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 34% Potential Upside for Biotech Investors

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical innovator focused on muscle disorder therapies, is capturing investor attention with a compelling potential upside of 34.33%. With a..

Ultragenyx Pharmaceutical Inc. (RARE) Investor Outlook: 63% Potential Upside Amid Promising Biotech Developments

Navigating the complex landscape of biotechnology investments requires a keen eye for both innovation and financial metrics. Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a leading player in..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a 19.72% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) stands as a pivotal player in the rapidly evolving healthcare sector, specifically within the health information services industry. Based in New..

Omnicell, Inc. (OMCL) Stock Analysis: 56.50% Potential Upside Beckons Investors

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare technology sector, presents an intriguing opportunity for investors seeking growth within the health information services industry...

GRAIL, Inc. (GRAL)

⚠️ No article content returned.

..

Harrow, Inc. (HROW) Stock Analysis: Healthcare Innovator with a Promising 117.62% Upside

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its bold strides in the healthcare sector, particularly within the specialty and generic drug manufacturing..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Look at 127% Potential Upside in the Biotech Sector

Dyne Therapeutics, Inc. (NASDAQ: DYN), a pioneering force in the biotechnology sector, is catching the eye of investors with a remarkable potential upside of 127.31%. With..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 16.52% Potential Upside in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI) stands at the forefront of the healthcare sector, specializing in medical instruments and supplies vital for infusion therapy, vascular access, and..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Gem with 12% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands out in the biotechnology sector with its impressive portfolio of biopharmaceutical assets and recent robust growth metrics. Headquartered in Jupiter,..

Aveanna Healthcare Holdings Inc (AVAH): Strong Analyst Consensus and Promising Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH), a prominent player in the healthcare sector, stands out in the Medical Care Facilities industry with its diverse range of..

Viridian Therapeutics, Inc. (VRDN)

⚠️ No article content returned.

..

Opko Health, Inc. (OPK) Stock Analysis: Can a 154.6% Upside Justify the Risks?

Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is generating buzz among investors with a potential upside of 154.6%, as indicated by its average target..

Alphatec Holdings, Inc. (ATEC): Investor Outlook Reveals 44.82% Potential Upside Amid Robust Revenue Growth

Investors seeking opportunities in the healthcare sector might find Alphatec Holdings, Inc. (NASDAQ: ATEC) an intriguing proposition. With a market capitalization of $1.68 billion, this Carlsbad,..

SS Innovations International (SSII) Stock Analysis: A Healthcare Disruptor with 195% Upside Potential

Investors seeking opportunities in the healthcare sector may want to turn their attention to SS Innovations International Inc. (SSII), a commercial-stage surgical robotics company that has..

Evotec SE (EVO) Stock Analysis: Exploring a 176.71% Potential Upside Amid Strategic Collaborations

Evotec SE (NASDAQ: EVO), a Germany-based healthcare innovator, stands at a pivotal juncture with a compelling potential upside of 176.71%. With a market capitalization of $540.19..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Navigating Growth Potential Amidst Strong Technical Indicators

Pacira BioSciences, Inc. (NASDAQ: PCRX) is at the forefront of developing non-opioid pain management solutions, a critical segment in the healthcare sector given the ongoing opioid..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 113.8% Upside in the Biotechnology Sector

Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing opportunity for investors willing to navigate the volatile waters of the biotechnology sector. With a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring Growth Potential Amidst Market Volatility

10x Genomics, Inc. (NASDAQ: TXG) has emerged as a significant player in the healthcare sector, particularly within the medical devices industry. Headquartered in Pleasanton, California, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds